Compound ID | 407

Update compound information

SC 44914

Class: Cell-wall synthesis inhibitor (quinoxaline)

Details of activity: No activity against Campylobacter jejuni but more active than SC 44942A and metronidazole against C. difficile
Description: Segreti J, Goodman LJ, Kerns L, et al. In vitro activity of two new quinoxaline compounds against Campylobacter sp. and Clostridium difficile. 31st-ICAAC 1991;161.
Institute where first reported: Searle Pharm. (Pharmacia Corporation, USA)
Year first mentioned: 1991
Highest developmental phase: Preclinical
Development status: Inactive
Chemical structure(s):
Click here for structure editor
Molecular weight: 320.39
Iso. SMILES: CCC1(CN=C2C(=[N+](C3=C(N2C1)C=CN=C3)[O-])C4=CC=CC=C4)C
InChI Key: XQIXJYNCQWWVOB-UHFFFAOYSA-N
Can. SMILES: CCC1(C)CN=C2C(=[N+](C3=C(C=CN=C3)N2C1)[O-])C4=CC=CC=C4
InChI: InChI=1S/C19H20N4O/c1-3-19(2)12-21-18-17(14-7-5-4-6-8-14)23(24)16-11-20-10-9-15(16)22(18)13-19/h4-11H,3,12-13H2,1-2H3
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/3082744
Citation: https://www.sciencedirect.com/science/article/pii/0732889393900312?via%3Dihub

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.